A Major Overhaul of Prescription Drug Prices

For years, music fans have said they felt ripped off by Ticketmaster and Live Nation, its parent company. Last week, a jury ruled that they were right, and that the company is a monopoly. Ben Sisario, who covers the music industry for The New York Times, breaks down the trial tha ...  Show more

From the moment Kash Patel was appointed as the director of the F.B.I., he has invited controversy and concern about what his leadership would look like and how it might affect the agency. The New York Times journalists Emily Bazelon and Rachel Poser spoke to dozens of current an ...  Show more

The Biden administration on Tuesday shared the first ten prescription drugs that it has chosen for price negotiations through Medicare. The Biden administration will try to lower Medicare prices for the drugs by negotiating with their respective manufacturers to ease the burden o ...  Show more

In the first of two episodes this week, we're taking a deep dive into the pharmaceutical industry.

How much does the medication you take actually cost? What if a company came along and bought the rights to a particular drug and started charging double, triple, or even 1 ...

The government announced the first ten drugs that are the subject of price negotiations between the U.S. government and private companies. For decades, the government has been prohibited from negotiating the price it pays through Medicare for medication — until the rule was relax ...  Show more

Drug policy feels very unsettled right now. The war on drugs was a failure. But so far, the war on the war on drugs hasn’t entirely been a success, either.

Take Oregon. In 2020, it became the first state in the nation to decriminalize hard drugs. It was a paradigm shift ...